These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 27789766)

  • 1. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
    Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
    J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles.
    Mahmoud AM; Szczurek MR; Blackburn BK; Mey JT; Chen Z; Robinson AT; Bian JT; Unterman TG; Minshall RD; Brown MD; Kirwan JP; Phillips SA; Haus JM
    Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27796268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin limits insulin action in obese/insulin-resistant humans.
    Lteif A; Vaishnava P; Baron AD; Mather KJ
    Diabetes; 2007 Mar; 56(3):728-34. PubMed ID: 17327443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.
    Chun KH; Choi KD; Lee DH; Jung Y; Henry RR; Ciaraldi TP; Kim YB
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E536-42. PubMed ID: 21189360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects.
    Kashyap SR; Roman LJ; Lamont J; Masters BS; Bajaj M; Suraamornkul S; Belfort R; Berria R; Kellogg DL; Liu Y; DeFronzo RA
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1100-5. PubMed ID: 15562034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, insulin resistance, and skeletal muscle nitric oxide synthase.
    Kraus RM; Houmard JA; Kraus WE; Tanner CJ; Pierce JR; Choi MD; Hickner RC
    J Appl Physiol (1985); 2012 Sep; 113(5):758-65. PubMed ID: 22797309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.
    Kim YB; Nikoulina SE; Ciaraldi TP; Henry RR; Kahn BB
    J Clin Invest; 1999 Sep; 104(6):733-41. PubMed ID: 10491408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity.
    Koh HE; van Vliet S; Meyer GA; Laforest R; Gropler RJ; Klein S; Mittendorfer B
    Diabetologia; 2021 May; 64(5):1158-1168. PubMed ID: 33511440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
    Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
    J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats.
    Eringa EC; Stehouwer CD; Roos MH; Westerhof N; Sipkema P
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1134-9. PubMed ID: 17623751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprint interval and moderate-intensity continuous training have equal benefits on aerobic capacity, insulin sensitivity, muscle capillarisation and endothelial eNOS/NAD(P)Hoxidase protein ratio in obese men.
    Cocks M; Shaw CS; Shepherd SO; Fisher JP; Ranasinghe A; Barker TA; Wagenmakers AJ
    J Physiol; 2016 Apr; 594(8):2307-21. PubMed ID: 25645978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
    Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
    Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals.
    Pendergrass M; Bertoldo A; Bonadonna R; Nucci G; Mandarino L; Cobelli C; Defronzo RA
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E92-100. PubMed ID: 16896161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
    Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
    Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
    Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.